Massachusetts Financial Services’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $836K | Buy |
177,050
+2,191
| +1% | +$10.3K | ﹤0.01% | 831 |
|
2025
Q1 | $803K | Sell |
174,859
-3,988
| -2% | -$18.3K | ﹤0.01% | 817 |
|
2024
Q4 | $857K | Sell |
178,847
-5,334
| -3% | -$25.6K | ﹤0.01% | 821 |
|
2024
Q3 | $864K | Buy |
+184,181
| New | +$864K | ﹤0.01% | 801 |
|
2024
Q2 | – | Sell |
-136,340
| Closed | -$560K | – | 894 |
|
2024
Q1 | $560K | Sell |
136,340
-303
| -0.2% | -$1.25K | ﹤0.01% | 806 |
|
2023
Q4 | $577K | Sell |
136,643
-4,316
| -3% | -$18.2K | ﹤0.01% | 794 |
|
2023
Q3 | $609K | Sell |
140,959
-5,401
| -4% | -$23.3K | ﹤0.01% | 792 |
|
2023
Q2 | $965K | Sell |
146,360
-3,449
| -2% | -$22.7K | ﹤0.01% | 751 |
|
2023
Q1 | $1.02M | Sell |
149,809
-4,234
| -3% | -$28.7K | ﹤0.01% | 755 |
|
2022
Q4 | $1.14M | Buy |
154,043
+3,261
| +2% | +$24.1K | ﹤0.01% | 765 |
|
2022
Q3 | $1.49M | Sell |
150,782
-1,375
| -0.9% | -$13.6K | ﹤0.01% | 755 |
|
2022
Q2 | $1.66M | Buy |
152,157
+768
| +0.5% | +$8.37K | ﹤0.01% | 743 |
|
2022
Q1 | $1.71M | Buy |
151,389
+1,554
| +1% | +$17.6K | ﹤0.01% | 765 |
|
2021
Q4 | $2.35M | Sell |
149,835
-3,035
| -2% | -$47.6K | ﹤0.01% | 764 |
|
2021
Q3 | $2.62M | Sell |
152,870
-2,006
| -1% | -$34.4K | ﹤0.01% | 754 |
|
2021
Q2 | $3.33M | Buy |
154,876
+71,101
| +85% | +$1.53M | ﹤0.01% | 736 |
|
2021
Q1 | $1.26M | Sell |
83,775
-14,389
| -15% | -$216K | ﹤0.01% | 821 |
|
2020
Q4 | $1.29M | Sell |
98,164
-987
| -1% | -$13K | ﹤0.01% | 778 |
|
2020
Q3 | $958K | Buy |
+99,151
| New | +$958K | ﹤0.01% | 777 |
|
2019
Q1 | – | Sell |
-58,810
| Closed | -$1.54M | – | 872 |
|
2018
Q4 | $1.54M | Buy |
58,810
+4,587
| +8% | +$120K | ﹤0.01% | 732 |
|
2018
Q3 | $1.25M | Buy |
+54,223
| New | +$1.25M | ﹤0.01% | 769 |
|
2018
Q2 | – | Sell |
-12,957
| Closed | -$218K | – | 867 |
|
2018
Q1 | $218K | Buy |
12,957
+200
| +2% | +$3.37K | ﹤0.01% | 830 |
|
2017
Q4 | $194K | Buy |
12,757
+1,790
| +16% | +$27.2K | ﹤0.01% | 837 |
|
2017
Q3 | $196K | Buy |
+10,967
| New | +$196K | ﹤0.01% | 833 |
|
2017
Q2 | – | Sell |
-45,562
| Closed | -$638K | – | 884 |
|
2017
Q1 | $638K | Buy |
45,562
+541
| +1% | +$7.58K | ﹤0.01% | 790 |
|
2016
Q4 | $718K | Buy |
+45,021
| New | +$718K | ﹤0.01% | 793 |
|